Bard PowerPort litigation
Lawsuits allege that the Bard PowerPort implantable port catheter is prone to fracturing and migrating inside the body, causing infections, blood clots, and vascular damage.
Accepting cases“Editorial still-life photograph on a deep navy-blue ground, single soft directional light from the left, muted cool palette with a faint gold accent, generous negative space, no people, no text, no logos, shot on large-format film, a small implantable port device with a thin catheter line, macro product photograph on dark ground”
What the lawsuits allege
The PowerPort is implanted under the skin to give clinicians repeated access to a vein, frequently during chemotherapy. The litigation alleges the catheter material can degrade and crack under normal use, sending fragments toward the heart and creating sites for serious infection, and that the manufacturer downplayed those failure rates.
Cases are coordinated in a federal multidistrict litigation that continues to accept new claims.
Injuries named in the litigation
- Catheter fracture with fragments migrating
- Bloodstream infection and sepsis
- Blood clots and deep vein thrombosis
- Cardiac puncture or arrhythmia
- Emergency removal surgery
Who may qualify
If you had a Bard PowerPort implanted and suffered a catheter fracture, serious infection, blood clot, or required unplanned removal surgery, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.